CoChat

RETRACTED: Ligand‐induced differentiation of glucocorticoid receptor (GR) trans‐repression and transactivation: preferential targetting of NF‐ κ B and lack of I‐ κ B involvement

Open access
Adcock, Ian M, Nasuhara, Yasuyuki, Stevens, David A, Barnes, Peter J · 1999 · British Journal of Pharmacology
Cited by 119

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Glucocorticoids are highly effective in controlling chronic inflammatory diseases, such as asthma and rheumatoid arthritis, but the exact molecular mechanism of their anti‐inflammatory action remains uncertain. They act by binding to a cytosolic receptor (GR) resulting in activation or repression of gene expression. This may occur via direct binding of the GR to DNA (transactivation) or by inhibition of the activity of transcription factors such as AP‐1 and NF‐κB (transrepression). The topically active steroids fluticasone propionate (EC 50 =1.8×10 −11 M ) and budesonide (EC 50 =5.0×10 −11 M ) were more potent in inhibiting GM‐CSF release from A549 cells than tipredane (EC 50 =8.3×10 −10 M ), butixicort (EC 50 =3.7×10 −8 M ) and dexamethasone (EC 50 =2.2×10 −9 M ). The anti‐glucocorticoid RU486 also inhibited GM‐CSF release in these cells (IC 50 =1.8×10 −10 M ). The concentration‐dependent ability of fluticasone propionate (EC 50 =9.8×10 −10 M ), budesonide (EC 50 =1.1×10 −9 M ) and dexamethasone (EC 50 =3.6×10 −8 M ) to induce transcription of the β 2 ‐receptor was found to correlate with GR DNA binding and occurred at 10–100 fold higher concentrations than the inhibition of GM‐CSF release. No induction of the endogenous inhibitors of NF‐κB, IκBα or I‐κBβ, was seen at 24 h and the ability of IL‐1β to degrade and subsequently induce IκBα was not altered by glucocorticoids. The ability of fluticasone propionate (IC 50 =0.5×10 −11 M ), budesonide (IC 50 =2.7×10 −11 M ), dexamethasone (IC 50 =0.5×10 −9 M ) and RU486 (IC 50 =2.7×10 −11 M ) to inhibit a 3×κB was associated with inhibition of GM‐CSF release. These data suggest that the anti‐inflammatory properties of a range of glucocorticoids relate to their ability to transrepress rather than transactivate genes. British Journal of Pharmacology (1999) 127 , 1003–1011; doi: 10.1038/sj.bjp.0702613

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0702613This paper is marked retracted.

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 119

Metadata

Authors
Adcock, I. M., Nasuhara, Y., Stevens, D. A., & Barnes, P. J.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1999-06
Volume
127
Issue
4
Pages
1003-1011
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2008781112
Cited by
119
References
3
FWCI
4.22
Type
journal article
Language
en
Status
Retracted
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.